Triad Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.39M Buy
9,759
+2,518
+35% +$587K 0.19% 90
2025
Q4
$1.5M Buy
7,241
+918
+15% +$182K 0.14% 107
2025
Q3
$1.17M Sell
6,323
-46
-0.7% -$7.88K 0.15% 106
2025
Q2
$973K Buy
6,369
+2,667
+72% +$410K 0.2% 90
2025
Q1
$614K Buy
3,702
+624
+20% +$97.6K 0.19% 89
2024
Q4
$445K Buy
+3,078
New +$477K 0.16% 98
2024
Q3
Sell
-2,210
Closed -$323K 491
2024
Q2
$323K Buy
2,210
+351
+19% +$52.2K 0.17% 59
2024
Q1
$294K Buy
+1,859
New +$296K 0.23% 43

Other funds holding JNJ

Triad Wealth Partners's JNJ Position: Q1 2026 in Review

Triad Wealth Partners increased its Johnson & Johnson (JNJ) stake by 35% in Q1 2026, buying an estimated $587K and bringing the position to 9,759 shares worth $2.39M. The position accounts for 0.19% of the portfolio, ranked #90.

Triad Wealth Partners first reported a position in JNJ in Q1 2024 and has held it in 8 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Triad Wealth Partners held 9,759 shares of Johnson & Johnson worth $2.39M as of Q1 2026.
  • Triad Wealth Partners bought 2,518 Johnson & Johnson shares in Q1 2026, an estimated $587K.
  • Johnson & Johnson made up 0.19% of Triad Wealth Partners's portfolio in Q1 2026, its #90 holding.
  • Triad Wealth Partners first reported a position in Johnson & Johnson in Q1 2024 and has held it in 8 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Triad Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.